Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein SA pseudogene 5 (*RPSAP5*) is a member of the processed pseudogene family related to the ribosomal protein SA gene (*RPSA*)[1][2]. Pseudogenes like *RPSAP5* typically arise from retrotransposition, resulting in non-functional copies that are usually not expressed as proteins[6][8]. There is no evidence that *RPSAP5* encodes a functional protein, acts as a receptor, or has a direct role in human disease or as a pharmacologic target[1][2][4]. Its parental gene, *RPSA*, is both a ribosomal protein and the laminin receptor, but *RPSAP5* itself does not share these properties[7]. Is there something wrong with this target? Yes. *RPSAP5* is a pseudogene, not a functional protein, enzyme, or receptor, and thus is not considered a valid biomedical target for drug discovery or therapeutic intervention[1][2][4]. Any reference treating it as a receptor or functional protein is not supported by experimental data. If you require information on the *functional* ribosomal protein SA or laminin receptor, you should refer to *RPSA* (canonical name: Ribosomal protein SA)[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein SA pseudogene 5 (RPSAP5).